Tags |
|
|
Cases - Fulfillment Companies
Although companies have much in common with one another, they also differ in many ways. Some companies are la
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
rge, some are small and some operate in only one product area, others operate in many diversified areas. Some
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
operate in a small geographic area whereas others do business in many countries of the world. To cope with t
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
hese varied objectives, strategies and situations, companies adopt different structures.
Departmentation is
Departmentation is
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
he process of dividing the company into manageable subunits. The subunits are often referred to as departmen
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ts, divisions or sections. So many flexible structures are adopted these days to meet the specific needs of t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
he companies. When low cost and efficiency are the keys to successful goal achievement, fulfillment companies
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
should use functional departmentation. It involves grouping employees according to broad tasks they perform
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
Normally, separate departments are created for all the key activities of the business.
For example, in a ma
For example, in a ma
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
nufacturing company, the activities essential to the existence of the company are production, marketing and f
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
inance. However, in non- manufacturing concerns these functions differ. In a transport company, the key areas
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
may be operations, sales and finance. If the company is large, or in other words, as the company grows major
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
departments can be subdivided. The essential idea is to take advantage of specialization.
If the company is
If the company is
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
big and operates in a stable environment, it can afford to formalize the structure. The greater the intensity
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
of competition, the greater will be the degree of decentralization. The greater the volatility of the enviro
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
nment, the more decentralized and flexible company has to be and companies that implement the organizational
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
tyle appropriate to their strategy will be more effective than those that use an in-appropriate style.
The q
The q
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
uestion that what kind of structure is best has no single right answer. It depends on the situation. Some com
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
pany need stable systems while some other needed flexible systems. The nature of the task, technology, enviro
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
nment and the needs of the company members are some of the factors that influence the design of the structure
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.cases.org.ua/article/3921/cases-Fulfillment-Companies.html">Fulfillment Companies</a>
BB link (for phorums):
[url=http://www.cases.org.ua/article/3921/cases-Fulfillment-Companies.html]Fulfillment Companies[/url]
Related Articles:
Medical Billing - GE0 Record Fields 1 Through 8
Bookmark it:
|